Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Grossman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
p19ARF targets certain E2F species for degradationF Martelli, T Hamilton, D P Silver, et al.
Molecular Cell|November 11, 1998
p300/MDM2 complexes participate in MDM2-mediated p53 degradationS R Grossman, M Perez, A L Kung, et al.
Molecular and Cellular Biology|November 14, 2000
Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycleS Miyake, W R Sellers, M Safran, et al.
Oncogene|April 18, 2017
Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasiaE T Sumner, A T Chawla, A D Cororaton, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2001
p19ARF targets certain E2F species for degradationF Martelli, T Hamilton, D P Silver, et al.
Molecular Cell|November 11, 1998
p300/MDM2 complexes participate in MDM2-mediated p53 degradationS R Grossman, M Perez, A L Kung, et al.
Molecular and Cellular Biology|November 14, 2000
Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycleS Miyake, W R Sellers, M Safran, et al.
Oncogene|April 18, 2017
Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasiaE T Sumner, A T Chawla, A D Cororaton, et al.
Pageof 3